NCT00612885 - Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study | Biotech Hunter

Enrollment

425

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions

OsteoarthritisArthritis, Rheumatoid

Trial Locations (11)

Boehringer Ingelheim Investigational Site, Busan

Boehringer Ingelheim Investigational Site, Daegu

Boehringer Ingelheim Investigational Site, Daejeon

Boehringer Ingelheim Investigational Site, Gangwondo

Boehringer Ingelheim Investigational Site, Gwangju

Boehringer Ingelheim Investigational Site, Gyeongbuk

Boehringer Ingelheim Investigational Site, Gyeonggido

Boehringer Ingelheim Investigational Site, Gyeongnam

Boehringer Ingelheim Investigational Site, Jeonnam

Boehringer Ingelheim Investigational Site, Jungbuk

Boehringer Ingelheim Investigational Site, Seoul